ICA Group Wealth Management’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

ICA Group Wealth Management’s Portfolio ARDS Stock Details ARDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-250	Closed	-$55	–	1327
2023 Q2	$55	Hold	250	–	–	﹤0.01%	1323
2023 Q1	$79	Hold	250	–	–	﹤0.01%	1260
2022 Q4	$295	Buy	+250	New	+$241	﹤0.01%	1263

Other funds holding ARDS

Wealth Architects Mountain View, California $1.27B AUM 36.93% 1-Year Est. Return

ICA Group Wealth Management's ARDS Position: Q3 2023 in Review

ICA Group Wealth Management sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q3 2023, closing a stake of 250 shares — an estimated $55 sold.

ICA Group Wealth Management first reported a position in ARDS in Q4 2022 and held it in 3 quarters. The position peaked at $295 in Q4 2022. 1 fund tracked by Wall St. Rank holds ARDS as of Q3 2023.

ICA Group Wealth Management reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
ICA Group Wealth Management sold 250 Aridis Pharmaceuticals Inc. Common Stock shares in Q3 2023, an estimated $55.
ICA Group Wealth Management first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q4 2022 and held it in 3 quarters.
ICA Group Wealth Management's Aridis Pharmaceuticals Inc. Common Stock position peaked at $295 in Q4 2022.
1 fund tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q3 2023.

Based on ICA Group Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.